JANUS HENDERSON GROUP PLC - 31 Mar 2025 SCHEDULE 13G/A Report for LEXEO THERAPEUTICS, INC. Common Stock (LXEO)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
LEXEO THERAPEUTICS, INC. Common Stock
Symbol
LXEO
Shares outstanding
33,269,489 shares
Disclosed Ownership
4,557,920 shares
Ownership
14%
Form type
SCHEDULE 13G/A
Filing time
14 May 2025, 12:00:47 UTC
Date of event
31 Mar 2025
Previous filing
14 Feb 2025
Next filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 14% 4,557,920 0 4,557,920 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 8.1% 2,683,874 0 2,683,874 Kristin Mariani Head of North America Compliance, CCO